| ALK1 | Activin Receptor-Like Kinase 1 |
| ATF4 | Activating Transcription Factor-4 |
| AVMs | Arteriovenous Malformations |
| BMP | Bone Morphogenetic Protein |
| BOECs | Blood Outgrowth Endothelial Cells |
| EE | Ethinyl Estradiol |
| EMA | European Medicine Agency |
| eNOS | Endothelial NO Synthase |
| ENT ER |
Ear Nose Throat Estrogen Receptor |
| EREs | Estrogen-Responsive Elements |
| ERK | Extracellular Signal-Regulated Kinase |
| ESS | Epistaxis Severity Score |
| FDA | Food and Drug Administration |
| FGF | Fibroblast Growth Factor |
| HB-EGF | Heparin Binding EGF Like Growth Factor |
| HHT | Hereditary Hemorrhagic Telangiectasia |
| ICTRP | WHO International Clinical Trials Registry Platform |
| IH | Infantile Hemangiomas |
| IPF | Idiopathic Pulmonary Fibrosis |
| IMiDs | Immunomodulatory Imide Drugs |
| JP-HHT | HHT-Juvenile Polyposis |
| MAPK | Mitogen Activated Protein Kinase |
| MEK | Mitogen-Activated Extracellular Signal-Regulated Kinase 1 |
| MMPs | Metalloproteinases |
| NAC | N-acetylcysteine |
| NMD | Nonsense Mediated Decay |
| PDGF-B | Platelet Derived Growth Factor-B |
| PI3K | Phosphatidyl Inositol 3-Kinase |
| PTC | Premature Termination Codon |
| QoL RCT |
Quality of Life Randomized Controlled Trial |
| SERM | Selective Estrogen Receptor Modulator |
| TA | Tranexamic Acid |
| TGF-β | Transforming Growth Factor β |
| TKIs | Tyrosine Kinase Inhibitors |
| TKR | Tyrosine Kinase Receptors |
| TNFα | Tumor Necrosis Factor-α |
| VASCERN | European Reference Network on Rare Multisystemic Vascular Diseases |
| VEGF-A | Vascular Endothelial Growth Factor-A |